Blocking the PROX1 protein allowed KAIST researchers to regenerate damaged retinas and restore vision in mice. Vision is one ...

In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in ...

In some patients with advanced triple-negative breast cancer, Trodelvy plus Keytruda was associated with an improvement in disease progression.

Pausing treatment during vaccination did not improve immunity in patients with chronic lymphocytic leukemia and should not be ...

Emerging biotech leader AKESF develops Ivonescimab & Cadonilimab; while offering growth potential with US partnerships, ...

More than 800 people in the U.S. have had measles since the beginning of the year, according to NBC News data. The majority ...

Advancements in mRNA vaccine technology are reshaping medicine, addressing challenges and expanding applications from ...

A test called the Titer test, which measures the levels of antibodies in a blood sample, is available at some national chain pharmacies including CVS and Walgreens. Most children should receive two ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

Here's three main ways to type your blood: One of the easiest and most effective ways to determine your blood type is to have ...

Allergy medications not doing the job this season? Experts explain why allergy immunotherapy may be the newest answer to ...

The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who ...